Skip to main content
Top
Published in: Archives of Virology 5/2008

01-05-2008 | Original Article

Phylogeny and molecular genetic parameters of different stages of hepatitis B virus infection in patients from the Brazilian Amazon

Authors: Cíntia Mara de Oliveira, Izeni Pires Farias, José Carlos Ferraz da Fonseca, Leila Melo Brasil, Rita de Souza, Spartaco Astolfi-Filho

Published in: Archives of Virology | Issue 5/2008

Login to get access

Abstract

A fragment of 600 bp of the gene which codes for the surface antigen of hepatitis B virus (HBV) was amplified and sequenced from patients who were born in five states of the Brazilian Amazon (Amazonas, Pará, Acre, Rondônia and Tocantins). A total of 44 sequences were used for the estimation of molecular genetic parameters and phylogenetic analyses. Compared with patients who were asymptomatic, those who had acute hepatitis and chronic liver disease had higher levels of genetic variability and higher rates of nucleotide substitutions. The analysis of transition and transversion substitutions showed that transition-type substitutions predominated. In chronic liver disease carriers, transversion-type substitutions showed phylogenetic saturation. In general, all of the analyses carried out in this study showed an association between patterns of changes in molecular genetic parameters and the stage of disease progression. Phylogenetic analysis using the HKY85 model of evolution identified 41 individuals as genotype A, suggesting its predominance in the Amazon region, one individual as genotype C, and one individual closely related to genotypes E and F.
Literature
1.
go back to reference Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) A new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83:2059–2073PubMed Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO (2002) A new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83:2059–2073PubMed
2.
go back to reference Bowyer SM, Sim GM (2000) Relationships within and between genotypes of hepatitis B virus at points across the genome: footprints of recombination in certain isolates. J Gen Virol 81:379–392PubMed Bowyer SM, Sim GM (2000) Relationships within and between genotypes of hepatitis B virus at points across the genome: footprints of recombination in certain isolates. J Gen Virol 81:379–392PubMed
3.
go back to reference Couroucé-Pauty AM, Plancon A, Soulier JP (1983) Distribution of HBsAg subtypes in the world. Vox Sang 44:197–211PubMed Couroucé-Pauty AM, Plancon A, Soulier JP (1983) Distribution of HBsAg subtypes in the world. Vox Sang 44:197–211PubMed
4.
go back to reference Dane DS, Cameron CH, Briggs M (1970) Virus-like particles in serum of patients with Australia-antigen associated hepatitis. Lancet 1:695–698PubMedCrossRef Dane DS, Cameron CH, Briggs M (1970) Virus-like particles in serum of patients with Australia-antigen associated hepatitis. Lancet 1:695–698PubMedCrossRef
5.
go back to reference Dumpis U, Holmes EC, Mendy M, Hill A, Thursz M, Hall A, Whittle H, Karayiannis P (2001) Transmission of hepatitis B virus infection in Gambia families revealed by phylogenetic analysis. J Hepatol 35:99–104PubMedCrossRef Dumpis U, Holmes EC, Mendy M, Hill A, Thursz M, Hall A, Whittle H, Karayiannis P (2001) Transmission of hepatitis B virus infection in Gambia families revealed by phylogenetic analysis. J Hepatol 35:99–104PubMedCrossRef
6.
go back to reference Fares M, Holmes E (2002) A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 54:807–814PubMedCrossRef Fares M, Holmes E (2002) A revised evolutionary history of hepatitis B virus (HBV). J Mol Evol 54:807–814PubMedCrossRef
7.
go back to reference Felsenstein J (2004) Inferring phylogenies. Sinauer Associates, Inc., Sunderland Felsenstein J (2004) Inferring phylogenies. Sinauer Associates, Inc., Sunderland
8.
go back to reference Ganem D, Varmus HE (1987) The molecular biology of the hepatitis B viruses. Annu Rev Biochem 56:651–693PubMedCrossRef Ganem D, Varmus HE (1987) The molecular biology of the hepatitis B viruses. Annu Rev Biochem 56:651–693PubMedCrossRef
9.
go back to reference Gu X, Fu YX, Li WH (1995) Maximum likelihood estimation of the heterogeneity of substitution rate among nucleotide sites. Mol Biol Evol 12:546–557PubMed Gu X, Fu YX, Li WH (1995) Maximum likelihood estimation of the heterogeneity of substitution rate among nucleotide sites. Mol Biol Evol 12:546–557PubMed
10.
go back to reference Hall T (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98 Hall T (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 41:95–98
11.
go back to reference Hannoun C, Horal P, Lindh M (2000) Long-term mutation rates in the hepatitis B virus genome. J Gen Virol 81:75–83PubMed Hannoun C, Horal P, Lindh M (2000) Long-term mutation rates in the hepatitis B virus genome. J Gen Virol 81:75–83PubMed
12.
go back to reference Hasegawa M, Kishino H, Yano TA (1985) Dating of the human–ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 22:160–174PubMedCrossRef Hasegawa M, Kishino H, Yano TA (1985) Dating of the human–ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 22:160–174PubMedCrossRef
13.
go back to reference Huelsenbeck JP, Ronquist FR (2001) MRBAYES: Bayesian inference of phylogeny. Bioinformatics 17:754–755PubMedCrossRef Huelsenbeck JP, Ronquist FR (2001) MRBAYES: Bayesian inference of phylogeny. Bioinformatics 17:754–755PubMedCrossRef
14.
go back to reference Kao JH, Chen PJ, Lai MY, Chen DS (2002) Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 40:1207–1209PubMedCrossRef Kao JH, Chen PJ, Lai MY, Chen DS (2002) Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 40:1207–1209PubMedCrossRef
15.
go back to reference Karasawa T, Aizawa Y, Zeniya M, Kuramoto A, Shirasawa T, Toda G (1995) Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen-negative chronic hepatitis B patients: spontaneous seroconversion and interferon-induced seroconversion. J Med Virol 45:373–380PubMedCrossRef Karasawa T, Aizawa Y, Zeniya M, Kuramoto A, Shirasawa T, Toda G (1995) Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen-negative chronic hepatitis B patients: spontaneous seroconversion and interferon-induced seroconversion. J Med Virol 45:373–380PubMedCrossRef
16.
go back to reference Kidd-Ljunggren K, Miyakawa Y, Kidd A (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83:1267–1280PubMed Kidd-Ljunggren K, Miyakawa Y, Kidd A (2002) Genetic variability in hepatitis B viruses. J Gen Virol 83:1267–1280PubMed
17.
go back to reference Kramvis A, Weitzmann L, Owiredu WKBA, Kew M (2002) Analysis of the complete genome of subgroup A′ hepatitis B virus isolates from South Africa. J Gen Virol 83:835–839PubMed Kramvis A, Weitzmann L, Owiredu WKBA, Kew M (2002) Analysis of the complete genome of subgroup A′ hepatitis B virus isolates from South Africa. J Gen Virol 83:835–839PubMed
18.
go back to reference Lauder IJ, Lin HJ, Lau JYN, Siu TS, Lai CL (1993) The variability of the Hepatitis B virus genome: statistical analysis and biological implicationsNor. Mol Biol Evol 10:457–470PubMed Lauder IJ, Lin HJ, Lau JYN, Siu TS, Lai CL (1993) The variability of the Hepatitis B virus genome: statistical analysis and biological implicationsNor. Mol Biol Evol 10:457–470PubMed
19.
go back to reference Li W-H (1997) Molecular evolution. Sinauer Associates, Sunderland Li W-H (1997) Molecular evolution. Sinauer Associates, Sunderland
20.
go back to reference Mangnius LO, Norder H (1995) Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38:24–34 Mangnius LO, Norder H (1995) Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38:24–34
21.
go back to reference Moraes MTB, Gomes SA, Niel C (1996) Sequence analysis of pre-S/S gene of hepatitis B virus strains of genotypes A, D, and F isolated in Brazil. Arch Virol 141:01–07CrossRef Moraes MTB, Gomes SA, Niel C (1996) Sequence analysis of pre-S/S gene of hepatitis B virus strains of genotypes A, D, and F isolated in Brazil. Arch Virol 141:01–07CrossRef
22.
go back to reference Nakano T, Ling L, Hu X, Mizokami M, Orito E, Shapiro C, Hadler S, Robertson B (2001) Characterization of hepatitis B virus genotype among Yucpa indians in Venezuela. J Gen Virol 82:359–365PubMed Nakano T, Ling L, Hu X, Mizokami M, Orito E, Shapiro C, Hadler S, Robertson B (2001) Characterization of hepatitis B virus genotype among Yucpa indians in Venezuela. J Gen Virol 82:359–365PubMed
23.
go back to reference Niel C, Moraes MTB, Gaspar AMC, Yoshida CFT, Gomes AS (1994) Genetic diversity of hepatitis B virus strains isolated in Rio de Janeiro, Brazil. J Med Virol 44:180–186PubMedCrossRef Niel C, Moraes MTB, Gaspar AMC, Yoshida CFT, Gomes AS (1994) Genetic diversity of hepatitis B virus strains isolated in Rio de Janeiro, Brazil. J Med Virol 44:180–186PubMedCrossRef
24.
go back to reference Norder H, Courouce AM, Magnius LO (1994) Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198:489–503PubMedCrossRef Norder H, Courouce AM, Magnius LO (1994) Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198:489–503PubMedCrossRef
25.
go back to reference Norder H, Couroucé A, Coursaget P, Echevarria JM, Lee S, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef Norder H, Couroucé A, Coursaget P, Echevarria JM, Lee S, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO (2004) Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289–309PubMedCrossRef
26.
go back to reference Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69:2575–2583PubMedCrossRef Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo RI, Imai M, Miyakawa Y, Mayumi M (1988) Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69:2575–2583PubMedCrossRef
27.
go back to reference Orito E, Mizokami M, Ina Y, Moriyama EN, Kameshima N, Yamamoto M, Gojobori T (1989) Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci USA 86:7059–7062PubMedCrossRef Orito E, Mizokami M, Ina Y, Moriyama EN, Kameshima N, Yamamoto M, Gojobori T (1989) Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci USA 86:7059–7062PubMedCrossRef
28.
go back to reference Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk G (2006) Molecular evolution of hepatitis B virus over 25 years. J Virol 80:10307–10314PubMedCrossRef Osiowy C, Giles E, Tanaka Y, Mizokami M, Minuk G (2006) Molecular evolution of hepatitis B virus over 25 years. J Virol 80:10307–10314PubMedCrossRef
29.
go back to reference Pan CQ, Zhang JX (2005) Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci 2:36–40PubMed Pan CQ, Zhang JX (2005) Natural history and clinical consequences of hepatitis B virus infection. Int J Med Sci 2:36–40PubMed
30.
go back to reference Posada D, Crandall KA (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14:817–818PubMedCrossRef Posada D, Crandall KA (1998) MODELTEST: testing the model of DNA substitution. Bioinformatics 14:817–818PubMedCrossRef
31.
go back to reference Starkman SE, MacDonald DM, Lewis JCM, Holmes EC, Simmonds P (2003) Geographic and species association of hepatitis B virus genotypes in non-human primates. Virology 314:381–393PubMedCrossRef Starkman SE, MacDonald DM, Lewis JCM, Holmes EC, Simmonds P (2003) Geographic and species association of hepatitis B virus genotypes in non-human primates. Virology 314:381–393PubMedCrossRef
32.
go back to reference Stuyver L, De Gendt S, Van Geyt C, Zoulim FZ, Fried M, Schinazi RF, Rossau R (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81:67–74PubMed Stuyver L, De Gendt S, Van Geyt C, Zoulim FZ, Fried M, Schinazi RF, Rossau R (2000) A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81:67–74PubMed
33.
34.
go back to reference Yang Z (1993) Maximum-likelihood estimation of phylogeny from DNA sequences when substitution rates differ over sites. Mol Biol Evol 10:1396–1401PubMed Yang Z (1993) Maximum-likelihood estimation of phylogeny from DNA sequences when substitution rates differ over sites. Mol Biol Evol 10:1396–1401PubMed
Metadata
Title
Phylogeny and molecular genetic parameters of different stages of hepatitis B virus infection in patients from the Brazilian Amazon
Authors
Cíntia Mara de Oliveira
Izeni Pires Farias
José Carlos Ferraz da Fonseca
Leila Melo Brasil
Rita de Souza
Spartaco Astolfi-Filho
Publication date
01-05-2008
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 5/2008
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-008-0053-6

Other articles of this Issue 5/2008

Archives of Virology 5/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.